As this Monday March 22, AstraZeneca laboratory stated their vaccine was 79% effective and show no risk of thromboses (blood clots), this Thursday March 25, the Swedish-British laboratory reviewed data as required by the NIAID (National Institute of Allergy and Infections Diseases), and announced updated data including vaccine was 76% effective.